Device type · GWM
Device, Monitoring, Intracranial Pressure
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GWM
Neurology
Device class
Class II
FDA decisions since 2015
18
510(k), De Novo and PMA
Adverse event reports
322
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Device, Monitoring, Intracranial Pressure
- Product code
- GWM
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1620
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for GWM
Latest FDA decisions
The 8 newest of 18 since 2015.
K252241 · Decided Apr 10, 2026 · 267 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
K250285 · Decided Aug 29, 2025 · 210 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
Braincare Desenvolvimento E Inovação Tecnológica S.A.
K240821 · Decided Jul 18, 2024 · 115 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
Integra Lifesciences Production Corporation
K232890 · Decided Feb 4, 2024 · 139 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
- B4C System510(k)
Braincare Desenvolvimento E Inovacao Tecnologica S.A.
K201989 · Decided Oct 8, 2021 · 448 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
- CereLink ICP Monitor510(k)
Integra Lifesciences Production Corporation
K210993 · Decided Apr 30, 2021 · 28 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
K201118 · Decided May 26, 2020 · 29 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
K200630 · Decided Apr 9, 2020 · 30 days after receipt
Device type: Device, Monitoring, Intracranial Pressure (GWM) · Neurology & Neurosurgery
Reports received
322
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
229
71% of reports
Injury reports
90
28% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 76 | 8 | 0 | 0 |
| Jan 24 | 66 | 19 | 2 | 0 |
| Feb 24 | 54 | 12 | 0 | 0 |
| Mar 24 | 51 | 9 | 0 | 0 |
| Apr 24 | 55 | 14 | 0 | 0 |
| May 24 | 38 | 13 | 0 | 0 |
| Jun 24 | 23 | 9 | 1 | 0 |
| Jul 24 | 34 | 21 | 0 | 0 |
| Aug 24 | 32 | 21 | 0 | 0 |
| Sep 24 | 43 | 12 | 2 | 0 |
| Oct 24 | 18 | 16 | 0 | 1 |
| Nov 24 | 30 | 10 | 1 | 0 |
| Dec 24 | 26 | 8 | 0 | 0 |
| Jan 25 | 47 | 4 | 0 | 0 |
| Feb 25 | 17 | 11 | 1 | 0 |
| Mar 25 | 16 | 4 | 0 | 0 |
| Apr 25 | 41 | 7 | 0 | 0 |
| May 25 | 25 | 8 | 0 | 0 |
| Jun 25 | 17 | 5 | 0 | 0 |
| Jul 25 | 29 | 8 | 0 | 0 |
| Aug 25 | 22 | 8 | 0 | 0 |
| Sep 25 | 38 | 8 | 0 | 0 |
| Oct 25 | 37 | 11 | 0 | 0 |
| Nov 25 | 31 | 7 | 0 | 0 |
| Dec 25 | 36 | 8 | 0 | 0 |
| Jan 26 | 19 | 12 | 0 | 0 |
| Feb 26 | 13 | 17 | 0 | 0 |
| Mar 26 | 16 | 6 | 0 | 0 |
| Apr 26 | 10 | 3 | 0 | 0 |
| May 26 | 26 | 9 | 0 | 0 |
| Jun 26 | 13 | 7 | 0 | 0 |
| Jul 26 | 22 | 6 | 0 | 1 |
| Aug 26 | 13 | 4 | 0 | 0 |
| Sep 26 | 12 | 7 | 0 | 0 |
| Oct 26 | 18 | 4 | 0 | 2 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak60
- Break58
- Fracture53
- Incorrect, Inadequate or Imprecise Result or Readings34
- Device Sensing Problem24
- Incorrect Measurement23
- Unexpected Shutdown22
- Disconnection20
- No Device Output14
- Nonstandard Device13
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions238
- Insufficient Information71
- Cerebrospinal Fluid Leakage3
- Device Embedded In Tissue or Plaque3
- Foreign Body In Patient3
- Hemorrhage/Blood Loss/Bleeding3
- Unspecified Infection2
- Abrasion1
- Discomfort1
- Pain1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Integra LifeSciences Corp. (NeuroSciences)
Z-1036-2026 · Started Dec 12, 2025 · Posted by FDA Jan 8, 2026
Reason given: Potential corrosion stains on the surface of the 14-gauge Tuohy Needle that is included in the Microsensor and Cerelink ICP Kits.
Cause as FDA categorized it: Process control
Integra LifeSciences Corp. (NeuroSciences)
Z-1037-2026 · Started Dec 12, 2025 · Posted by FDA Jan 8, 2026
Reason given: Potential corrosion stains on the surface of the 14-gauge Tuohy Needle that is included in the Microsensor and Cerelink ICP Kits.
Cause as FDA categorized it: Process control
- The Pressio 2 ICP Monitoring System, Model Number PSO-4000; Intracranial Pressure MonitorOpen, Classified
Z-1029-2026 · Started Nov 17, 2025 · Posted by FDA Jan 8, 2026
Reason given: Customer complaints of Pressio monitor rebooting.
Cause as FDA categorized it: Software design
Z-0661-2025 · Started Nov 1, 2024 · Posted by FDA Dec 19, 2024
Reason given: Due to complaints received reporting cracks and/or leaks of the stopcocks associated with the external drainage and monitoring system (EDMS).
Cause as FDA categorized it: Under Investigation by firm
Z-0662-2025 · Started Nov 1, 2024 · Posted by FDA Dec 19, 2024
Reason given: Due to complaints received reporting cracks and/or leaks of the stopcocks associated with the external drainage and monitoring system (EDMS).
Cause as FDA categorized it: Under Investigation by firm
- medex TranStar Single OR Set 1/EA, Product Code REF MX20846R2Open, Classified
Z-0182-2025 · Started Sep 24, 2024 · Posted by FDA Oct 23, 2024
Reason given: Due to a manufacturing defect, users may experience inaccurate pressure monitoring, an interruption in pressure monitoring, or an inability to zero the device due to either a leak within the TranStar Disposable Pressure Transducer or from a defect within the TranStar Disposable Pressure Transducer chip.
Cause as FDA categorized it: Process control
- medex TranStar Single ICP Set 1/EA, Product Code REF MX20897Open, Classified
Z-0183-2025 · Started Sep 24, 2024 · Posted by FDA Oct 23, 2024
Reason given: Due to a manufacturing defect, users may experience inaccurate pressure monitoring, an interruption in pressure monitoring, or an inability to zero the device due to either a leak within the TranStar Disposable Pressure Transducer or from a defect within the TranStar Disposable Pressure Transducer chip.
Cause as FDA categorized it: Process control
Z-1825-2024 · Started Apr 9, 2024 · Posted by FDA May 15, 2024
Reason given: An increase in claims related to leakage of cerebrospinal fluid (CSF) from the proximal end of the catheter. In the event of a leak going undetected during implantation, it could pose an infectious risk to the patient. The cause of the leaks is indicated to be manufacturing error involving perforation of the inner...
Cause as FDA categorized it: Process change control
Showing the 8 newest of 52 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.